Madrid, 28 jun (EFE).-the Minister of health, social services and equality, Ana Mato, today announced that his Department is working on a new Royal Decree which will regulate the clinical trials with medicinal products, with the aim of improving the position of Spain in Europe regarding this research.

“are given all the circumstances to advance” in this field, has today declared Mato during the awards ceremony of research biomedical of the founding Lilly, according to a statement from his Ministry.

Mato has advanced in addition the forthcoming establishment of the Advisory Council of the Ministry, which will feature two researchers awarded by the Lilly Foundation.

the position of Spain in Europe in terms of number of approved clinical trials has remained unchanged in recent years, has remained between 700 and 750, approximately, noted Mato, who has announced that the new rules will prevent “unnecessary obstacles”.

is Menschenhandel eine wichtige Reform, weist darauf hin, da “die Verbesserung der Gesundheitsindikatoren, unter anderem auf Innovation im Bereich der Arzneimittel unterstützt wird”.

in diesem Sinne hat Mato gratuliert der Lilly-Stiftung “für ihr Engagement” in diesem Feld daran erinnert, dass die Werke, die den Award für die biomedizinische Forschung gewonnen haben, die diese Entität in den 11 Jahren ihres Bestehens, liefert, das Wissen über Krebs, Herz-Kreislauf-Erkrankungen, Diabetes, Alzheimer und anderen neurodegenerativen Erkrankungen. verbessert haben

der Minister nimmt diese Gelegenheit, um die nächste Verfassung des Beirats des Ministeriums für Gesundheit, soziale Dienste und Gleichheit zu verkünden. Der Teil, sagte er, Experten in der biomedizinischen Forschung, klinische Medizin, Pflege, Pharmazie, Pharmakologie, Biochemie und Gesundheitsökonomie.